Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
about
Antibody therapies for lymphoma in childrenAntibody therapies for lymphoma in childrenEarly-life exposures to infectious agents and later cancer developmentBeyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, MalawiBiomarkers of HIV-associated Cancer.Aggressive B-cell lymphomas: how many categories do we need?The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.Antibody therapy of pediatric B-cell lymphomaRasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group ReportMature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.Risk factors for the evaluation of potential central nervous system metastasis in Burkitt's lymphoma: a case study and literature review.Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.Adolescent and young adult non-Hodgkin lymphoma.Oculomotor nerve palsy as a preceding symptom of adult sporadic Burkitt lymphoma: A case report and review of the literatureSilent presentation of multiple metastasis Burkitt lymphoma in a child: A case report and review of the literature.A step towards the cure of Burkitt's lymphoma in developing countriesLong non-coding RNAs in B-cell malignancies: a comprehensive overview.Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice.Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.Non-Hodgkin lymphoma, diagnostic, and prognostic particularities in children - a series of case reports and a review of the literature (CARE compliant).Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA).
P2860
Q24186437-76550D74-A64E-416D-A49E-CE22C84DB34FQ24195106-DD6F9D46-493B-43E4-B241-614409C9765FQ26786103-1AE64078-6E57-44AF-A6E1-59148D77FAB3Q33834535-9AAE888F-6E51-419F-BA77-0E7BB1C80E7FQ33856851-3FED0E1A-419A-4EBC-986E-C2B46827591EQ35527893-5EC74227-80CF-463F-BC94-87881DC28838Q35691157-B9DDB8DB-9D02-442D-B638-9BB3A989D99CQ36732959-3CD2806B-6097-4B5D-829D-C4B24787A9A9Q37329442-AD069068-21A2-405E-9073-AC6EB55F373EQ38097544-84BA7658-65F3-4CCD-AA8D-898A497F5DB7Q38259829-D4156BF1-421A-4D5B-A926-382FBEBAACA4Q38536238-3B3391C6-2E74-41C8-A06B-0BA773EDC07FQ38687541-27ECBDF0-24BB-4855-891A-882A98965B94Q38806478-C633C41C-0FCC-4DD2-B8A0-1D114F572A16Q39270336-BDCDC87E-04A0-4CF8-B93C-07A943EC5282Q39430793-89E77420-4027-41D7-9274-0476084F8862Q41561637-1D66BF18-054F-4089-B34A-C0444288E36EQ41694305-D5ABC948-3F39-46BE-8729-1FD6B163934DQ47951320-D4AE3FE8-DE4C-4CE4-BB60-A3EC627D540EQ48140288-BC46BBFD-F66C-471C-BB80-EF2B182DA31DQ49712163-F8FB29E4-38BB-40A2-8C46-9738BC441D94Q50352275-5CCD0399-2076-48C0-9208-833450E94E61Q55406123-DA4ED8C6-D382-4A94-A2FC-C700AE57C423
P2860
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@en
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@nl
type
label
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@en
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@nl
prefLabel
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@en
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@nl
P2093
P2860
P921
P1476
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
@en
P2093
Mitchell S Cairo
Rodney R Miles
Staci Arnold
P2860
P304
P356
10.1111/J.1365-2141.2011.09024.X
P407
P577
2012-01-20T00:00:00Z